tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DMAC Stock Latest News

DiaMedica Therapeutics Raises Capital via Share Offering
Company AnnouncementsDiaMedica Therapeutics Raises Capital via Share Offering
16d ago
8K
DMAC
DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street
PremiumThe Fly
DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street
16d ago
DMAC
DiaMedica Therapeutics provides DM199 update following FDA meeting
PremiumThe Fly
DiaMedica Therapeutics provides DM199 update following FDA meeting
1M ago
DMAC
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting
PremiumCompany Announcements
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting
1M ago
DMAC
Buy Rating Affirmed for Diamedica Therapeutics Amid Promising DM199 Trial Progress
PremiumRatings
Buy Rating Affirmed for Diamedica Therapeutics Amid Promising DM199 Trial Progress
2M ago
DMAC
Microsoft initiated, Home Depot downgraded: Wall Street’s top analyst calls
PremiumThe FlyMicrosoft initiated, Home Depot downgraded: Wall Street’s top analyst calls
2M ago
HD
MP
DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
DMAC
DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
DiaMedica Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
DMAC
DiaMedica Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
DiaMedica Therapeutics Reports Q3 2025 Financial Results
2M ago
DMAC
DiaMedica Therapeutics’ Earnings Call: Mixed Outlook
PremiumCompany Announcements
DiaMedica Therapeutics’ Earnings Call: Mixed Outlook
2M ago
DMAC
DiaMedica Therapeutics Reports Q3 2025 Financial Results and Clinical Progress
PremiumCompany Announcements
DiaMedica Therapeutics Reports Q3 2025 Financial Results and Clinical Progress
2M ago
DMAC
DiaMedica Therapeutics reports Q3 EPS (17c), consensus (16c)
PremiumThe Fly
DiaMedica Therapeutics reports Q3 EPS (17c), consensus (16c)
2M ago
DMAC
DMAC Earnings this Week: How Will it Perform?
PremiumPre-EarningsDMAC Earnings this Week: How Will it Perform?
2M ago
DMAC
DiaMedica Therapeutics initiated with a Buy at TD Cowen
Premium
The Fly
DiaMedica Therapeutics initiated with a Buy at TD Cowen
3M ago
DMAC
Buy Rating for Diamedica Therapeutics: Promising Potential of DM199 in Preeclampsia Treatment
Premium
Ratings
Buy Rating for Diamedica Therapeutics: Promising Potential of DM199 in Preeclampsia Treatment
3M ago
DMAC
ReMEDy2 Trial: A Potential Game-Changer for Acute Ischemic Stroke Treatment
PremiumCompany Announcements
ReMEDy2 Trial: A Potential Game-Changer for Acute Ischemic Stroke Treatment
3M ago
DMAC
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
DiaMedica Therapeutics’ Earnings Call Highlights Progress and Challenges
5M ago
DMAC
Buy Rating for Diamedica Therapeutics Driven by Promising Phase 2 Results of DM199 in Preeclampsia
PremiumRatings
Buy Rating for Diamedica Therapeutics Driven by Promising Phase 2 Results of DM199 in Preeclampsia
5M ago
DMAC
DiaMedica Therapeutics Advances with Positive Trials and Funding
PremiumCompany Announcements
DiaMedica Therapeutics Advances with Positive Trials and Funding
5M ago
DMAC
DiaMedica Therapeutics Enters Sales Agreement with TD Securities
PremiumCompany AnnouncementsDiaMedica Therapeutics Enters Sales Agreement with TD Securities
5M ago
8K
DMAC
DiaMedica Therapeutics files $100M mixed securities shelf
Premium
The Fly
DiaMedica Therapeutics files $100M mixed securities shelf
5M ago
DMAC
DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
Premium
The Fly
DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)
5M ago
DMAC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >